Patent classifications
C07C49/577
SUBSTITUTED 1,2,3,4-TETRAHYDRO-1,1'-BIPHENYL COMPOUNDS
Provided herein are substituted 1,2,3,4-tetrahydro-1,1-biphenyl compounds and methods of making same.
SUBSTITUTED 1,2,3,4-TETRAHYDRO-1,1'-BIPHENYL COMPOUNDS
Provided herein are substituted 1,2,3,4-tetrahydro-1,1-biphenyl compounds and methods of making same.
Synthesis of cannabinoids
Provided are synthesis processes and intermediates for preparing cannabinoids and analogs.
Synthesis of cannabinoids
Provided are synthesis processes and intermediates for preparing cannabinoids and analogs.
INHIBITION OF RESPIRATORY COMPLEX III BY LIGANDS THAT INTERACT WITH A REGULATORY SWITCH
The present invention provides methods for inhibiting respiratory complex III in a cell. The present invention also provides methods for treating cancer in a subject.
Synthetic route to anhydroryanodol, ryanodol and structural analogues
This disclosure is related to methods for producing anhydroryanodol, ryanodol, or analogs thereof and novel compounds prepared thereby.
Synthetic route to anhydroryanodol, ryanodol and structural analogues
This disclosure is related to methods for producing anhydroryanodol, ryanodol, or analogs thereof and novel compounds prepared thereby.
Inhibition of respiratory complex III by ligands that interact with a regulatory switch
The present invention provides methods for inhibiting respiratory complex III in a cell. The present invention also provides methods for treating cancer in a subject.
Inhibition of respiratory complex III by ligands that interact with a regulatory switch
The present invention provides methods for inhibiting respiratory complex III in a cell. The present invention also provides methods for treating cancer in a subject.
Heteroaromatic chalcone derivatives and their medical use
The present invention relates to heteroaromatic chalcone derivatives, particularly the compounds of formula (I) as described and defined herein, pharmaceutical compositions comprising these compounds, and their medical use, including their use in the treatment or prevention of cancer and, in particular, in the treatment or prevention of hematologic malignancies. ##STR00001##